Giovanni Amoroso è il nuovo presidente della Consulta, che si è riunita stamani per eleggere il successore di Augusto Barbera, il cui mandato è terminato un mese fa. Amoroso è stato eletto all ...

Giovanni Amoroso, 76 anni, è il nuovo presidente della Corte costituzionale e succede così ad Augusto Barbera che ha terminato il suo incarico al vertice della Consulta lo scorso 21 dicembre ...

Former Strictly Come Dancing professional Giovanni Pernice has named the six people he still keeps in touch with from the BBC series. Giovanni, 34, recently admitted that he would "love to go back ...

Giovanni Amoroso, esperto in diritto penale e civile, giuslavorista, è il nuovo presidente della Corte Costituzionale, è stato appena eletto all'unanimità alla Presidenza della Corte ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. From reproductive rights to climate change to Big Tech, The ...

Gilead Sciences’ Livdelzi (seladelpar) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat adults with the rare liver disease primary biliary cholangitis (PBC) ...

GS-0272 is under clinical development by Gilead Sciences and currently in Phase I for Rheumatoid Arthritis. According to GlobalData, Phase I drugs for Rheumatoid Arthritis have a 69% phase transition ...

Giovanni Pernice has given an intimate glimpse into his new relationship with Bianca Guaccero, an Italian actress and singer. The professional dancer, 34, who met Bianca, 44, on Ballando con le ...

Giovanni Pernice has opened up about his chances of a Strictly Come Dancing return (Picture: BBC) Strictly Come Dancing professional Giovanni Pernice has revealed his fear that he will never be ...

Giovanni Pernice got his fans fired up this week as the former Strictly Come Dancing professional shared an insight into his upcoming tour, The Last Dance. The Italian-born star shared a black-and ...

Gilead Sciences Inc. and the federal government settled a patent-infringement case in which the US sought $1 billion from the bioscience giant for allegedly using joint research to develop an ...